CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses
Research and development	$ 11,608	$ 9,165
General and administrative	4,235	4,736
Total operating expenses	15,843	13,901
Net operating loss	(15,843)	(13,901)
Other income
Interest income	36	33
Change in fair value of warrant liability	(271)
Total other income	(235)	33
Net loss	$ (16,078)	$ (13,868)
Net Loss Per Share, Basic
Net loss per share, basic	$ (33.63)	$ (38.12)
Weighted average number of common shares outstanding, basic	478	364
Net Loss Per Share, Diluted
Net loss per share, diluted	$ (33.63)	$ (38.12)
Weighted average number of common shares outstanding, diluted	478	364